Nanoparticulate Carriers for the treatment of Infectious Diseases and Cancer

Author(s): Neeraj Mishra

Journal Name: Current Molecular Pharmacology

Volume 14 , Issue 3 , 2021

Become EABM
Become Reviewer
Call for Editor

Singh, L.; Kruger, H.G.; Maguire, G.E.M. Thavendran Govender and Raveen Parboosing, the role of nanotechnology in the treatment of viral infections. Ther. Adv. Infectious Dis., 2017, 4(4), 105-131.
Ferrari, M. Cancer nanotechnology: Opportunities and challenges. Nat. Rev. Cancer, 2005, 5(3), 161.
Peer, D.; Karp, J.M.; Hong, S.; Farokhzad, O.C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol., 2007, 2(12), 751.
Shi, J.; Votruba, A.R.; Farokhzad, O.C.; Langer, R. Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano Lett., 2010, 10(9), 3223.
Swartz, M.A.; Hirosue, S.; Hubbell, J.A. Engineering approaches to Immunotherapy. Sci. Transl. Med., 2012, 4(148), 148-149.
Kearney, C.J.; Mooney, D.J. Macroscale delivery systems for molecular and cellular payloads. Nat. Mater., 2013, 12(11), 1004.
Albanese, A.; Tang, P.S.; Chan, W.C.W. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng., 2012, 14, 1.
Maeda, H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv. Drug Deliv. Rev., 2015, 91, 3.
L.E. Gerlowski, L.E. and Jain, R. K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res., 1986, 31(3), 288.
Farokhzad, O.C.; Langer, R. Impact of nanotechnology on drug delivery. ACS Nano, 2009, 3(1), 16.
Burgess, P.; Hutt, P.B. Farokhzad, O.C.; Langer R.; Minick, S.; Zale, S. On firm ground: IP protection of therapeutic nanoparticles. Nat. Biotechnol., 2010, 28(12), 1267.
Sun, T.; Zhang, Y.S.; Pang, B.; Hyun, D.C.; Yang, M.; Xia, Y. Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. Engl., 2014, 53(46), 12320.
Sutradhar, K.B.; Amin, M.L. Nanotechnology in cancer drug delivery and selective targeting; ISRN Nanotechnol, 2014. 1-13.
Srinivasan, M.M.; Rajabi, M.; Mousa, S. Multifunctional nanomaterials and their applications in drug delivery and cancer therapy. Nanomaterials, 2015, 5(4), 1690.
Bregoli, L.; Movia, D.; Gavigan-Imedio, J.D.; Lysaght, J.; Reynolds, J.; Prina-Mello, A. Nanomedicine applied to translational oncology: A future perspective on cancer treatment. Nanomedicine, 2016, 12(1), 81-103.
Palazzolo, S.; Bayda, S.; Hadla, M.; Caligiuri, I.; Corona, G.; Toffoli, G.; Rizzolio, F. The clinical translation of organic nanomaterials for cancer therapy: a focus on polymeric nanoparticles, micelles, liposomes and exosomes. Curr. Med. Chem., 2018, 25, 4224-4268.
Yao, Y.; Zhou, Y.; Liu, L.; Xu, Y.; Chen, Q.; Wang, Y.; Wu, S.; Deng, Y.; Zhang, J.; Shao, A. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance, Front. Mol. Biosci. 2020.
Bahrami, B.; Hojjat-Farsangi, M.; Mohammadi, H.; Anvari, E.; Ghalamfarsa, G.; Yousefi, M.; Jadidi-Niaragh, F. Nanoparticles and targeted drug delivery in cancer therapy. Immunol. Lett., 2017, 190, 64-83.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 23 September, 2021
Page: [261 - 262]
Pages: 2
DOI: 10.2174/187446721403210706114224

Article Metrics

PDF: 144